Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways

Cancer is one of the major causes of death in diabetic patients, and an association between antidiabetic drugs and cancer risk has been reported. Such evidence implies a strong connection between diabetes and cancer. Recently, glucagon has been recognized as a pivotal factor implicated in the pathop...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagi, Takashi, Kubota, Eiji, Koyama, Hiroyuki, Tanaka, Tomohiro, Kataoka, Hiromi, Imaeda, Kenro, Joh, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828215/
https://www.ncbi.nlm.nih.gov/pubmed/29535833
http://dx.doi.org/10.18632/oncotarget.24367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828215/
https://www.ncbi.nlm.nih.gov/pubmed/29535833
http://dx.doi.org/10.18632/oncotarget.24367

Ejemplares similares